It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

CureVac hoping for EU approval of Covid-19 jab by June

Thu 08 April 2021 11:52 | A A A

No recommendation

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

(Sharecast News) - German Covid vaccine maker CureVac is hoping that emergency use approval from the European Union for its coronavirus jab will be forthcoming by June.

According to the company's chief executive officer, Franz-Werner Haas, who spoke to CNBC on Thursday, the firm was close to completing the recruitment process for its phase three trials.

Indeed, he expected the trials would have the necessary data by the end of April or early May.

The vaccine will then have to be submitted for review by the watchdog and other regulators before it is cleared for use.

Haas was keenly aware of the urgent need for more vaccination options to combat the pandemic.

The UK and the EU had already pre-ordered 455m dosis from the drug-maker.

Curevac's boss also said that the company was trying to avoid the manufacturing pitfalls hit by other vaccine makers

"Manufacturing is certainly a struggle at the moment," he reportedly told the broadcaster.

"It's not only that we are producing by ourselves, but we have an entire network in Europe, with other companies supporting us with manufacturing there as well, but it's very hard sometimes to get the equipment, to get the facilities built-up but also the material to produce the mRNA.

"But we're doing everything to get as many doses produced as we can."

    The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.


    More company news from ShareCast